Insurance Guides

Can I Get Travel Insurance During Cancer Treatment?

Cover4You Editorial Team|25 April 2026|7 min read

Chemotherapy, radiotherapy, immunotherapy — which treatments affect your cover, and what do insurers need to know? A practical guide for Kiwis in active treatment.

Can I Get Travel Insurance During Cancer Treatment?

Many people need or want to travel during cancer treatment — to visit family, attend important life events, or simply for quality of life reasons. The question of whether travel insurance is available during active treatment is one of the most common we receive.

The answer: yes, in many cases — but with more complexity than for remission cases.

During active cancer treatment, the medical assessment asks more detailed questions:

  • The specific treatment you are on (drug names and regimen if chemotherapy)
  • Your treatment start date and expected end date
  • The schedule (e.g. "cycle 3 of 6, infusion every 3 weeks")
  • The most recent blood count results if available
  • Your oncologist's position on fitness to travel
  • The destination and duration of your planned trip
  • Why you are travelling during treatment

The more detail you can provide, the more accurately the insurer can assess your case.

IV Chemotherapy (most complex) Active intravenous chemotherapy — FOLFOX, CHOP, carboplatin/paclitaxel, or similar — is the most challenging treatment for insurance purposes. The reasons:

  • Blood counts fluctuate significantly through the cycle
  • The nadir period (lowest white cell count, typically 7–14 days post-infusion) carries high infection risk
  • Chemotherapy toxicities can be acute and require urgent specialist management

Most insurers will assess IV chemotherapy cases on a case-by-case basis. Some may offer cover only in the second half of the cycle (post-nadir); others may exclude chemotherapy complications but cover other travel risks. A few may be unable to cover at all during active IV chemotherapy.

Oral Chemotherapy (more manageable) Oral chemotherapy drugs (capecitabine/Xeloda, temozolomide, and similar) are generally assessed more favourably. Side effects are typically more predictable and blood count monitoring differs from IV regimens. Some insurers treat oral chemotherapy comparably to targeted therapy.

Radiotherapy Active radiotherapy courses (typically daily for 3–7 weeks) generally prevent long-distance travel anyway — patients must attend treatment sessions. Post-radiotherapy recovery is assessed differently and generally more favourably.

Targeted Therapy (most travel-friendly active treatment) Daily oral targeted therapies — EGFR inhibitors, ALK inhibitors, PARP inhibitors, CDK4/6 inhibitors — are the most travel-friendly active treatments. They don't typically cause neutropenia, side effects are often predictable, and they are taken as daily tablets easily packed in carry-on luggage. Insurers generally assess these cases similarly to stable cancer management.

Immunotherapy (case-by-case) Checkpoint inhibitors (pembrolizumab, nivolumab) are generally tolerated well for travel. The main insurance concern is immune-related adverse events (irAEs) — which, while relatively rare, can be serious. Insurers assess immunotherapy cases individually.

Hormone Therapy (most favourable) Hormone therapies are typically assessed very favourably — often comparable to remission cases with ongoing medication. Tamoxifen, aromatase inhibitors, ADT for prostate cancer are generally not barriers to obtaining cover.

Getting Your Oncologist's Clearance

This is non-negotiable. Before applying for travel insurance during active treatment:

  1. 1
    Discuss your travel plans with your oncologist — . Tell them where you want to go, for how long, and why. Ask for their honest view on fitness to travel.
  2. 2
    Get a letter confirming fitness to travel — . The letter should state your diagnosis, current treatment, and that your oncologist confirms you are medically fit for the trip.
  3. 3
    Ask about timing — . Your oncologist can advise the safest window in your treatment cycle for travel.

Without this letter, insurers may be reluctant to assess your case, and if you travel without medical clearance and suffer a treatment-related complication, your claim could be challenged.

The Value of Partial Cover During Treatment

Even if full cancer cover is not available during active treatment, a policy that covers:

  • Trip cancellation (for reasons other than cancer)
  • Baggage loss
  • Travel delays
  • Other medical emergencies (broken bone, dental emergency, appendicitis — unrelated to cancer)

…has real value. Treatment schedules change, unexpected events happen, and general travel insurance protection is worth having even if the cancer-specific cover cannot be provided.

Tips for Applying During Treatment

  • Be extremely specific about your treatment: drug names, cycle schedule, date of last infusion
  • Apply between cycles when your blood counts have recovered
  • Have your oncologist's letter ready before applying
  • Compare at least two providers — outcomes can differ significantly
  • If one insurer declines cancer cover, ask whether they can still provide a policy with cancer excluded
  • Don't assume "no cancer cover" means "no insurance available"

Ready to compare providers?

See all the major travel insurance providers for cancer patients side-by-side.

Compare All Providers →